10. Bibliografia

Considerata la mole delle consultazioni bibliografiche effettuate ed anche i tempi in cui ciò è stato fatto, la presente bibliografia è da ritenersi giocoforza incompleta. Sono compresi, senza distinzione palese nel testo, sia i riferimenti a lavori originali sia i riferimenti a lavori di revisione.

  1. Abate O., Vittone V., Zanatta R., Tarducci A., Borgarelli M., Bellino C., Cagnasso A. – Valutazione della proteinuria mediante SDS-AGE ai fini della localizzazione del danno renale nel cane e nel gatto – Veterinaria, Anno 19, n. 1, Febbraio 2005:9-14;
  2. Abranches P., Lopes F., Silva F.M.C., Ribeiro M.M.S., Pires C.A. – Le Kala-azar au Portugal. III. Résultats d’une enquête sur la leishmaniose canine réalisée dans les environs de Lisbone. Comparaison des zones urbaines et rurales – Ann. Parasitol. Hum. Comp. 1983;58(4):307-15 [link];
  3. Abranches P. : Reservoirs of visceral leishmaniasis – In Leishmaniasis. The Current Status and New Strategies for Control – Ed. D.T. Hart, Plenum Press, New York, 61-9, 1989;
  4. Amela C., Mendez I., Torcal J.M., Medina G., Pachón I., Cañavete C., Alvar J. – Epidemiology of canine leishmaniasis in the Madrid region, Spain – Eur. J. Epidemiol. 1995;11:1-5 [link];
  5. Amela C, López-Gay D, Alberdi JC, Castilla J – Injecting drug use as risk factor for visceral leishmaniasis in AIDS patients – Eur J Epidemiol. 1996 Feb;12(1):91-2 [link];
  6. Andrade HM, de Toledo Vde P, Marques MJ, França Silva JC, Tafuri WL, Mayrink W, Genaro O – Leishmania (Leishmania) chagasi is not vertically transmitted in dogs – Vet Parasitol. 2002 Jan 3;103(1-2):71-81 [link];
  7. Ashford R.W. – New strategies for control forum: reservoir control – in Leishmaniasis: the current status and new strategies for control, Plenum Press, New York, 1989:827-31;
  8. Ashford R.W. – Leishmaniasis reservoirs and their significance in control – Clin. Dermatol. 1996;14:523-32;
  9. Ballarini G. – Leishmaniosi canina e salute pubblica – Obiett. Doc. Vet. 1997;3:21-2;
  10. Baneth G, Shaw SE – Chemotherapy of canine leishmaniosis – Vet Parasitol. 2002 july 2;106(4):315-24 [link];
  11. Berrahal F., Mary C., Roze M., Berenger A., Escoffier K., Lamouroux D., Dunan S. – Canine leishmaniasis: identification of asymptomatic carriers by polymerase chain reaction and immunoblotting – Am. J. Trop. Med. Hyg. 1996 Sep;55(3):273-7 [link];
  12. Bianciardi P – Incontro Virbac™ per la presentazione del Milteforan® – Firenze, 26 settembre 2007;
  13. Biglino A, Bolla C, Concialdi E, Trisciuoglio A, Romano A, Ferroglio E – Asymptomatic Leishmania infantum infection in an area of northwestern Italy (Piedmont region) where such infections are traditionally nonendemic – J Clin Microbiol. 2010;48(1):131-6 [abstractHTML1HTML2PDF1PDF2];
  14. Bizzeti M. – La sieroelettroforesi per il controllo nel cane della leishmaniosi – Obiett. Doc. Vet. 1998;6:11-5;
  15. Boehme CC, Hain U, Novosel A, Eichenlaub S, Fleischmann E, Löscher T – Congenital Visceral Leishmaniasis [letter] – Emerg Infect Dis 2006 Feb;12(2) [linkPDF];
  16. Bogdan C, Schönian G, Bañuls AL, Hide M, Pratlong F, Lorenz E, Röllinghoff M, Mertens R – Visceral leishmaniasis in a German child who had never entered a known endemic area: case report and review of the literature – Clin Infect Dis. 2001 Jan 15;32(2):302-6. Epub 2000 Dec 29 [abstractHTMLPDF];
  17. Bourdoiseau G, Bonnefont C, Magnol JP, Saint-André I, Chabanne L – Lymphocyte subset abnormalities in canine leishmaniasis – Vet Immunol Immunopathol. 1997 May;56(3-4):345-51 [link];
  18. Bourdoiseau G. – Leishmaniose canine: protocoles therapeutiques, perspectives de controle – Atti Mondial Vet Lyon, 1999;
  19. Bray R.S. – The zoonotic potential of reservoirs of leishmaniasis in the Old World – Ecol. Dis. 1982;1:257-67 [link];
  20. Cabello I, Caraballo A, Millan Y – Leishmaniasis in the genital area – Rev Inst Med Trop Sao Paulo. 2002 Mar-Apr;44(2):105-7 [abstractHTMLPDF];
  21. Cain C, Stone MS, Thieberg M, Wilson ME – Nonhealing genital ulcers. Cutaneous leishmaniasis – Arch Dermatol. 1994 Oct;130(10):1313, 1315-6;
  22. Campino L.M. – Canine reservoirs and leishmaniasis: epidemiology and disease – in World Class Parasites: Volume 4 Leishmania (ed. Jay P. Farrell) 2002:45-57;
  23. Cardoso L, Neto F, Sousa JC, Rodrigues M, Cabral M – Use of a leishmanin skin test in the detection of canine Leishmania-specific cellular immunity – Vet Parasitol. 1998 Nov 16;79(3):213-20 [link];
  24. Casarosa L. – Leishmaniosi del cane – in Parassitologia degli animali domestici, Casa Ed. Ambrosiana, 1985:35-7;
  25. Cavaliero T., Arnold P., Mathis A., Glaus T., Hofmann-Lehmann R., Deplazes P. – Clinical, serologic, and parasitologic follow-up after long-term allopurinol therapy of dogs naturally infected with Leishmania infantum – J. Vet. Intern. Med. 1999;13(4):330-4 [link];
  26. Cerundolo R. – Terapia della leishmaniosi canina – Atti Incontro SIDEV 25 febbraio 2001;
  27. Chamizo C, Moreno J, Alvar J – Semi-quantitative analysis of cytokine expression in asymptomatic canine leishmaniasis – Vet Immunol Immunopathol. 2005 Jan 10;103(1-2):67-75 [link];
  28. Chulay JD, Bhatt SM, Muigai R, Ho M, Gachihi G, Were JB, Chunge C, Bryceson AD – A comparison of three dosage regimens of sodium stibogluconate in the treatment of visceral leishmaniasis in Kenya – J Infect Dis. 1983 Jul;148(1):148-55 [link];
  29. Ciaramella P., De Luna R. – Leishmaniosi del cane: aspetti clinico diagnostici – Obiett. Doc. Vet. 1999;4 suppl.:13-25;
  30. Cortadellas O, del Palacio MJ, Bayón A, Albert A, Talavera J – Systemic hypertension in dogs with leishmaniasis: prevalence and clinical consequences – J Vet Intern Med. 2006 Jul-Aug;20(4):941-7 [link];
  31. Costa C.H., Stewart J.M., Gomes R.B., Garcez L.M., Ramos P.K., Bozza M., Satoskar A., Dissanayake S., Santos R.S., Silva M.R., Shaw J.J., David J.R., Maguire J.H. – Asymptomatic human carriers of Leishmania chagasi – Am. J. Trop. Med. Hyg. 2002 Apr;66(4):334-7 [link];
  32. Courtenay O., Quinnell R.J., Garcez L.M., Shaw J.J., Dye C. – Infectiousness in a cohort of brazilian dogs: why culling fails to control visceral leishmaniasis in areas of high transmission – J. Infect. Dis. 2002 Nov 1;186(9):1314-20. Epub 2002 Oct 11 [abstractHTMLPDF];
  33. Cunha S., Freire M., Eulalio C., Cristosvao J., Netto E., Johnson Jr. W., Reed S.G., Badaró R. – Visceral leishmaniasis in a new ecological niche near a major metropolitan area of Brazil – Trans. R. Soc. Trop. Med. Hyg. 1995;89:155-8 [link];
  34. Dantas-Torres F. – The role of dogs as reservoirs of Leishmania parasites, with emphasis on Leishmania (Leishmania) infantum and Leishmania (Viannia) braziliensis – Vet. Parasitol. – 2007;149(3-4):139-46 [link];
  35. Dedet J.P. – Current Status of Epidemiology of Leishmaniases – In World Class Parasites: Volume 4 – Leishmania, ed. Jay P. Farrell, Kluwer Academic Publishers, Boston, Dordrech, London, 1-10, 2002;
  36. de Freitas E, Melo MN, da Costa-Val AP, Michalick MS – Transmission of Leishmania infantum via blood transfusion in dogs: potential for infection and importance of clinical factors – Vet Parasitol. 2006 Apr 15;137(1-2):159-67. Epub 2006 Jan 18 [link];
  37. de Lima V.M., Peiro J.R., de Oliveira Vasconcelos R. – IL-6 and TNF-alpha production during active canine visceral leishmaniasis – Vet Immunol Immunopathol. 2007 Jan 15;115(1-2):189-93. Epub 2006 Nov 9 [link];
  38. Denerolle P., Bourdoiseau G. – Combination allopurinol and antimony treatment versus antimony alone and allopurinol alone in the treatment of canine leishmaniasis (96 cases) – J. Vet. Intern. Med. 1999;13(5):413-5 [link];
  39. Deplazes P, Grimm F, Papaprodromou M, Cavaliero T, Gramiccia M, Christofi G, Christofi N, Economides P, Eckert J – Canine leishmaniosis in Cyprus due to Leishmania infantum MON1 – Acta Trop. 1998;71(2):169-78 [link];
  40. de Souza A.I., Juliano R.S., Gomes T.S., de Araujo Diniz S., Borges A.M., Tafuri W.L., de Lima Santos R. – Osteolytic osteomyelitis associated with visceral leishmaniasis in a dog – Vet. Parasitol. 2005 Apr 20;129(1-2):51-4 [link];
  41. Dey A, Singh S – Transfusion transmitted leishmaniasis: a case report and review of literature – Indian J Med Microbiol. 2006 Jul;24(3):165-70 [abstractHTML – PDF];
  42. Dietze R., Barros G.B., Teixeira L., Harris J., Michelson K., Falqueto A., Corey R. – Effect of eliminating seropositive canines on the transmission of visceral leishmaniasis in Brazil – Clin. Infect. Dis. 1997 Nov;25(5):1240-2 [abstractdocumento PDF];
  43. Diniz SA, Melo MS, Borges AM, Bueno R, Reis BP, Tafuri WL, Nascimento EF, Santos RL – Genital lesions associated with visceral leishmaniasis and shedding of Leishmania sp. in the semen of naturally infected dogs – Vet Pathol. 2005 Sep;42(5):650-8 [abstractHTMLPDF];
  44. Dipineto L., Manna L., Baiano A., Gala M., Fioretti A., Gravino A. E., Menna L. F. – Presence of Leishmania infantum in red foxes (Vulpes vulpes) in southern Italy – J. Wildl. Dis. 2007;43(3):518-20 [abstract – PDF];
  45. Dow S.W., LeCouteur R.A., Poss M.L., Beadleston D. – Central nervous system toxicosis with metronidazole treatment of dogs: five cases (1984-1987) – J. Am. Vet. Med. Assoc. 1989;195(3);365-8 [link];
  46. Dutta AK – Pursuit of medical knowledge: Charles Donovan (1863-1951) on kala-azar in India – J Med Biogr. 2008 May;16(2):72-6 [link];
  47. Dye C. – The logic of visceral leishmaniasis control – Am. J. Trop. Med. Hyg. 1996 55(2)125-30;
  48. Eltoum IA, Zijlstra EE, Ali MS, Ghalib HW, Satti MM, Eltoum B, el-Hassan AM – Congenital kala-azar and leishmaniasis in the placenta – Am J Trop Med Hyg. 1992 Jan;46(1):57-62 [link];
  49. Evans T.G., Teixeira M.J., Mcauliffe I.T., Vasconcelos I.A.B., Vasconcelos A.W., Sousa A. Q., Lima J.W.O., Pearson R.D – Epidemiology of visceral leishmaniasis in northeast Brazil – J Infect Dis. 1992;166(5):1124-32 [link];
  50. Fakhar M, Motazedian MH, Hatam GR, Asgari Q, Kalantari M, Mohebali M – Asymptomatic human carriers of Leishmania infantum: possible reservoirs for Mediterranean visceral leishmaniasis in southern Iran – Ann Trop Med Parasitol. 2008 Oct;102(7):577-83 [abstract];
  51. Fernández-Bellon H, Solano-Gallego L, Rodríguez A, Rutten VP, Hoek A, Ramis A, Alberola J, Ferrer L – Comparison of three assays for the evaluation of specific cellular immunity to Leishmania infantum in dogs – Vet Immunol Immunopathol. 2005 Aug 15;107(1-2):163-9 [link];
  52. Ferrer L. – Stato dell’arte della leishmaniosi canina: un modello che cambia – Atti II Congr. Internaz. Merial™ giugno 2000:67-70;
  53. Ferrer L, Solano-Gallego L, Arboix M, Alberola J – Evaluation of the specific immune response in dogs infected by Leishmania infantum. In: Thoday KL, Foil CS, Bond R (Eds.). Proceedings of the Fourth World Congress of Veterinary Dermatology, San Francisco, USA, Adv Vet Derm:92-9;
  54. Ferroglio E., Maroli M., Gastaldo S., Mignone W., Rossi L. – Canine leishmaniasis, Italy – Emerg. Infect. Dis. 2005 Oct;11(10):1618-20 [abstractHTMLPDF];
  55. Ferroglio E. – Incontro Idexx™ sulla leishmaniosi canina – Firenze, 18 marzo 2007;
  56. Figueiró-Filho EA, Duarte G, El-Beitune P, Quintana SM, Lemos Maia T – Visceral leishmaniasis (kala-azar) and pregnancy – Infect Dis Obstet Gynecol. 2004; 12(1): 31-40 [abstractPDF];
  57. Foglia Manzillo V., Piantedosi D., Cortese L. – Detection of Leishmania infantum in canine peripheral blood – Vet. Rec. 2005 Jan 29;156(5):151-2;
  58. Gangneux J.P., Chau F., Sulahian A., Derouin F., Garin Y.J. – Effects of immunosuppressive therapy on murine Leishmania infantum visceral leishmaniosis – Eur. Cytokine Netw. 1999 Dec;10(4):557-9 [linkHTML];
  59. Garnham P.C.C. – The Leishmanias, with special reference of the role of animal reservoirs – Am. Zool. 1965;5:141-51;
  60. Ghazanfari T., Hassan Z.M., Ebtekar M., Ahmadiani A., Naderi G., Azar A. – Garlic induces a shift in cytokine pattern in Leishmania major-infected BALB/c mice – Scand. J. Immunol. 2000 Nov;52(5):491-5 [link];
  61. Gieni R.S., Fang Y., Trinchieri G., Umetsu D.T., DeKruyff R.H. – Differential production of IL-12 in BALB/c and DBA/2 mice controls IL-4 versus IFN-gamma synthesis in primed CD4 lymphocytes – Int. Immunol. 1996 Oct;8(10):1511-20 [link];
  62. Ginel P.J., Lucena R., López R., Molleda M. – Use of allopurinol for maintenance of remission in dogs with leishmaniasis – J. Small An. Pract. 1998;39:271-4 [link];
  63. Giudice A, Camada I, Leopoldo PT, Pereira JM, Riley LW, Wilson ME, Ho JL, de Jesus AR, Carvalho EM, Almeida RP – Resistance of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis to nitric oxide correlates with disease severity in Tegumentary Leishmaniasis – BMC Infect Dis. 2007 Feb 22;7:7 [abstractHTMLPDF];
  64. Gradoni L., Maroli M., Gramiccia M., Mancianti F. – Leishmania infantum infection rates in Phlebotomus perniciosus fed on naturally infected dogs under antimonial treatment – Med. Vet. Entomol. 1987 Oct;1(4):339-42 [link];
  65. Gradoni L. – The diagnosis of canine leishmaniasis – in Second International Canine Leishmaniasis Forum (6-9 feb. 2002, Seville, Spain), Final programme – p.4;
  66. Gramiccia M. – “Eziologia e ciclo biologico”. In “La leishmaniosi canina”, ed. SCIVAC (Ev. Srl), 1-10, 1989;
  67. Guarga JL, Moreno J, Lucientes J, Gracia MJ, Peribáñez MA, Alvar J, Castillo JA – Canine leishmaniasis transmission: higher infectivity amongst naturally infected dogs to sand flies is associated with lower proportions of T helper cells – Res Vet Sci. 2000 Dec;69(3):249-53 [link];
  68. Guarga JL, Moreno J, Lucientes J, Gracia MJ, Peribáñez MA, Castillo JA – Evaluation of a specific immunochemotherapy for the treatment of canine visceral leishmaniasis – Vet Immunol Immunopathol. 2002 Sep 6;88(1-2):13-20 [link];
  69. Guetta F. – La leishmaniose canine: actualités – VF News 2000 Oct./Déc. 3:2-9;
  70. Guler M.L., Gorham J.D., Hsieh C.S., Mackey A.J., Steen R.G., Dietrich W.F., Murphy K.M. – Genetic susceptibility to Leishmania: IL-12 responsiveness in TH1 cell development – Science 1996 Feb 16;271(5251):984-7 [link];
  71. Handman E. – Leishmaniasis: Current Status of Vaccine Development – Clin. Microbiol. Rev., 2001 14(2):229-43 [abstractHTMLPDF]:
  72. Herwaldt BL, Juranek DD – Laboratory-acquired malaria, leishmaniasis, trypanosomiasis, and toxoplasmosis – Am J Trop Med Hyg. 1993 Mar;48(3):313-23 [link];
  73. Herwaldt BL – Laboratory-acquired parasitic infections from accidental exposures – Clin Microbiol Rev. 2001 Oct;14(4):659-88 [abstractHTMLPDF];
  74. Ikeda-Garcia FA, Lopes RS, Ciarlini PC, Marques FJ, Lima VM, Perri SH, Feitosa MM – Evaluation of renal and hepatic functions in dogs naturally infected by visceral leishmaniasis submitted to treatment with meglumine antimoniate – Res Vet Sci. 2007 Aug;83(1):105-8. Epub 2006 Dec 5 [link];
  75. Iqbal S.M., Murty J.G., Banerjee P.K., Vishwanathan K.A. – Metronidazole ototoxicity – report of two cases – J. Laryngol. Otol. 1999;113:355-7 [link];
  76. Kamhawi S., Belkaid Y., Modi G., Rowton E., Sacks D. – Protection against cutaneous leishmaniasis resulting from bites of uninfected sand flies – Science 2000;290:1351-4 [link];
  77. Keithly J.S., Langreth S. – Inefficacy of metronidazole in experimental infections of Leishmania donovani, L. mexicana and Trypanosoma brucei brucei – Am. J. Trop. Med. Hyg. 1983;32(3):485-96 [link];
  78. Kenney RT, Sacks DL, Gam AA, Murray HW, Sundar S – Splenic cytokine responses in Indian kala-azar before and after treatment – J Infect Dis. 1998 Mar;177(3):815-8 [link];
  79. Killick-Kendrick R., Rioux J.A., Bailly M., Guy M.W., Wilkes T.J., Guy F.M., Davidson I., Knechtli R., Ward R.D., Guilvard E., Périères J., Dubois H. – Ecology of leishmaniasis in the south of France. 20. Dispersal of Phlebotomus ariasi Tonnoir, 1921 as a factor in the spread of visceral leishmaniasis in the Cévennes – Ann. Parasitol. Hum. Comp. 1984;59(6):555-72 [link];
  80. Killick-Kendrick R., Wilkes T.J., Bailly M., Bailly I., Righton L.A. – Preliminary field observations on the flight speed of a phlebotomine sandfly – Trans. R. Soc. Trop. Med. Hyg. 1986;80(1):138-42 [link];
  81. Killick-Kendrick R. – Phlebotomine sand flies: biology and control – in World Class Parasites: Volume 4 Leishmania (ed. Jay P. Farrell) 2002:33-43;
  82. Killick-Kendrick R., Rioux J.A. – Mark-release-recapture of sand flies fed on leishmanial dogs: the natural life-cycle of Leishmania infantum in Phlebotomus ariasi – Parassitologia 2002 Jun;44(1-2):67-71 [link];
  83. Lamothe J. – Activity of amphotericin B in lipid emulsion in the initial treatment of canine leishmaniasis – J. Small An. Pract. 2001;42:170-5 [documento interno];
  84. Lamothe J. – La leishmaniose canine: limites diagnostiques de la sérologie à partir de deux cas cliniques – Prat. Méd. Chir. Anim. Comp. 2002;42 [documento interno];
  85. Lanotte G., Rioux J.A., Perieres J., Vollhardt Y. – Ecolgie des leishmaniases dans le sud de la France. 10. Les formes evolutives de la leishmaniase viscèrale canine – Ann. Parasitol. Hum. Comp. 1979 May-Jun;54(3):277-95 [link];
  86. Locksley R.M., Pingel S., Lacy D., Wakil A.E., Bix M., Fowell D.J. – Susceptibility to infectious diseases: Leishmania as a paradigme – J. Infect. Dis. 1999;179(Suppl. 2):305-8 [abstractdocumento PDF];
  87. Lubas G. – Appunti di ematologia clinica comparata – SEU 1997:91-93;
  88. Mancianti F., Mignone W., Galastri F. – Serologic survey for leishmaniasis in free-living red foxes (Vulpes vulpes) in Italy – J. Wildl. Dis. 1994;30(3):454-6 [abstractPDF];
  89. Mancianti F., Pedonese F., Fiorentini A., Melosi M., Giannini S. – Valutazione dell’efficacia dell’associazione amminosidina (Amminofarma®) – antimonio (Glucantim®) rispetto al solo antimonio nella terapia della leishmaniosi canina – Riv. Zoot. Vet. 1998;26(2):57-63;
  90. Mancianti F., Bizzeti M. – Terapia della leishmaniosi canina – Obiett. Doc. Vet. 2000;5:7-17;
  91. Maroli M., Rossi L., Baldelli R., Capelli G., Ferroglio E., Genchi C., Gramiccia M., Mortarino M., Pietrobelli M., Gradoni L. – The northward spread of leishmaniasis in Italy: evidence from retrospective and ongoing studies on the canine reservoir and phlebotomine vectors – Trop. Med. Int. Health. 2008;13(2):256-64 [abstractHTMLPDF];
  92. Martìnez-Subiela S., Tecles F., Eckersall P.D., Cerón J.J. – Serum concentrations of acute phase proteins in dogs with leishmaniasis – Vet. Rec. 2002 Feb 23;150(8):241-4 [link];
  93. Masucci M, De Majo M, Contarino RB, Borruto G, Vitale F, Pennisi MG – Canine leishmaniasis in the newborn puppy – Vet Res Commun. 2003 Sep;27 Suppl 1:771-4;
  94. McFarlane E, Perez C, Charmoy M, Allenbach C, Carter KC, Alexander J, Tacchini-Cottier F – Neutrophils contribute to the development of a protective immune response during the onset of infection with Leishmania donovani – Infect Immun. 2007 Dec 3 [Epub ahead of print] [link];
  95. Mercier P, Jasmin P, Sanquer A – Prevention of sand fly attack by topical application of a permethrin/pyriproxyfen combination on dogs – Vet Ther. 2003 Fall;4(3):309-16 [link];
  96. Miralles GD, Stoeckle MY, McDermott DF, Finkelman FD, Murray HW – Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis – Infect Immun. 1994 Mar;62(3):1058-63 [abstractPDF];
  97. Miranda S, Martorell S, Costa M, Ferrer L, Ramis A – Characterization of circulating lymphocyte subpopulations in canine leishmaniasis throughout treatment with antimonials and allopurinol – Vet Parasitol. 2007 Mar 31;144(3-4):251-60. Epub 2006 Nov 15 [link];
  98. Miró G, Gálvez R, Mateo M, Montoya A, Descalzo MA, Molina R – Evaluation of the efficacy of a topically administered combination of imidacloprid and permethrin against Phlebotomus perniciosus in dog – Vet Parasitol. 2007 Feb 28;143(3-4):375-9. Epub 2006 Oct 23 [link];
  99. Molina R., Amela C., Nieto J., San-Andres M., Gonzalez F., Castillo J.A., Lucientes J., Alvar J. – Infectivity of dogs naturally infected with Leishmania infantum to colonized Phlebotomus perniciosus – Trans. R. Soc. Trop. Med. Hyg. 1994 Jul-Aug;88(4):491-3 [link];
  100. Molina R, Espinosa-Góngora C, Gálvez R, Montoya A, Descalzo MA, Jiménez MI, Dado D, Miró G – Efficacy of 65% permethrin applied to dogs as a spot-on against Phlebotomus perniciosus – Vet Parasitol. 2012;187(3-4):529-33 [link];
  101. Moreira E.D. Jr., Mendes de Souza V.M., Sreenivasan M., Nascimento E.G., Pontes de Carvalho L. – Assessment of an optimized dog-culling program in the dynamics of canine Leishmania transmission – Vet. Parasitol. 2004;122(4):245-52 [link];
  102. Moreno J, Nieto J, Chamizo C, González F, Blanco F, Barker DC, Alva J – The immune response and PBMC subsets in canine visceral leishmaniasis before, and after, chemotherapy – Vet Immunol Immunopathol. 1999;71(3-4):181-95 [link];
  103. Moreno J., Alvar J. – Canine leishmaniasis: epidemiological risk and the experimental model – Trends Parasitol. 2002 Sep;18(9):399-405 [link];
  104. Moritz A., Steuber S., Greiner M. – Clinical follow-up examination after treatment of canine leishmaniasis – Tokai J. Exp. Clin. Med. 1999;23(6):279-83 [abstractPDF];
  105. Mougneau E., Altare F., Wakil A.E., Zheng S., Coppola T., Wang Z.E., Waldmann R., Locksley R.M., Glaichenhaus N – Expression cloning of a protective Leishmania antigen – Science 1995 Apr 28;268(5210):563-6 [link];
  106. Murray H.W., Delph-Etienne S. – Roles of endogenous gamma interferon and macrophage microbicidal mechanism in host response to chemotherapy in experimental visceral leishmaniasis – Infcet. Immun. 2000;68(1):288-93 [documento completo];
  107. Naranjo C., Fondevila D., Leiva M., Roura X., Pena T. – Characterization of lacrimal gland lesions and possible pathogenic mechanisms of keratoconjunctivitis sicca in dogs with leishmaniosis – Vet. Parasitol. 2005 Oct. 10;133(1):37-47 [link];
  108. Natale A. – La leishmaniosi in Italia – Obiett. Doc. Vet. 2004;12:23-8;
  109. Noli C. – La leishmaniosi del cane – Waltham Focus 1999;9(2):16-24;
  110. Norsworthy N.B., Sun J., Elnaiem D., Lanzaro G., Soong L. – Sand fly saliva enhances Leishmania amazonensis infection by modulating interleukin-10 production – Infect. Immun. 2004 Mar;72(3):1240-7 [abstractHTMLPDF];
  111. O’Garra A, Vieira P – TH1 cells control themselves by producing interleukin-10 – Nat Rev Immunol. 2007 Jun;7(6):425-8 [link];
  112. Oliva G., Cortese I., Ciaramella P., De Luna R. – Trattamento terapeutico della leishmaniosi del cane – Veterinaria 1996;10(3):115-27;
  113. Oliva G. – Atti Aggiornamenti sulla leishmaniosi canina – Calenzano (FI), 3 febbraio 2002;
  114. Oliva G – Incontro Virbac™ per la presentazione del Milteforan® – Firenze, 26 settembre 2007;
  115. Otranto D – Efficacia di un’associazione 10% imidacloprid/50% permetrina per la prevenzione della leishmaniosi canina in aree endemiche – Atti 56° Congr. Int. Multi. SCIVAC:393-5 – Rimini, giugno 2007 [PDF];
  116. Otranto D, Paradies P, Lia RP, Latrofa MS, Testini G, Cantacessi C, Mencke N, Galli G, Capelli G, Stanneck D – Efficacy of a combination of 10% imidacloprid/50% permethrin for the prevention of leishmaniasis in kennelled dogs in an endemic area – Vet Parasitol. 2007 Mar 31;144(3-4):270-8. Epub 2007 Jan 26 [link];
  117. Paranhos-Silva M, Freitas LA, Santos WC, Grimaldi G Júnior, Pontes-de-Carvalho LC, Oliveira-dos-Santos AJ – A cross-sectional serodiagnostic survey of canine leishmaniasis due to Leishmania chagasi – Am J Trop Med Hyg. 1996;55(1):39-44 [link];
  118. Pennisi M.G. – Chemioterapia della leishmaniosi canina: un capitolo aperto – Atti II Congr. Internaz. Merial™ giugno 2000:71-9;
  119. Pennisi M.G., De Majo M., Masucci M., Britti D., Vitale F., Del Maso R. – Efficacia della terapia combinata metronidazolo-spiramicina (Stomorgyl®) nel trattamento della leishmaniosi canina – Atti Second World Congress on Leishmaniasis, Creta, 20-24 maggio 2001 [documento interno];
  120. Pennisi M.G., De Majo M., Masucci M., Britti D., Vitale F., Del Maso R. – Efficacia della terapia della leishmaniosi canina con un’associazione di metronidazolo e spiramicina – Vet. Rec. 2005 Mar 12;156(11):346-9 [linkdocumento interno];
  121. Petanides TA, Koutinas AF, Mylonakis ME, Day MJ, Saridomichelakis MN, Leontides LS, Mischke R, Diniz P, Breitschwerdt EB, Kritsepi M, Garipidou VA, Koutinas CK, Lekkas S – Factors Associated with the Occurrence of Epistaxis in Natural Canine Leishmaniasis (Leishmania infantum) – J Vet Intern Med. 2008 Jun 18. [Epub ahead of print] [abstract];
  122. Pinelli E, Killick-Kendrick R, Wagenaar J, Bernadina W, del Real G, Ruitenberg J – Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum – Infect Immun. 1994 Jan;62(1):229-35 [abstractPDF];
  123. Pinelli E, van der Kaaij SY, Slappendel R, Fragio C, Ruitenberg EJ, Bernadina W, Rutten VP – Detection of canine cytokine gene expression by reverse transcription-polymerase chain reaction – Vet Immunol Immunopathol. 1999 Aug 2;69(2-4):121-6 [link];
  124. Pizzirani S. – Terapia delle leishmaniosi canine – in Prontuario Terapeutico veterinario SCIVAC 2001;
  125. Pizzirani S – Intervento sulla mailing list SCIVAC sulle modalità di somministrazione del Glucantime®;
  126. Prasad R, Kumar R, Jaiswal BP, Singh UK – Miltefosine: an oral drug for visceral leishmaniasis – Indian J Pediatr. 2004;71(2):143-4 [abstract];
  127. Prélaud P. – Allergologia canina – Prima ed. italiana (Edagricole) 2003:7;
  128. Puccini V. – Leishmaniosi dei cani – in Guida alle malattie parassitarie degli animali domestici, Edagricole, 1992:44-6;
  129. Ramos Franco A. M. – First World Congress on Leishmaniasis – World Leish 1 – Mem. Inst. Osw. Cruz 1997;92(6):867-70;
  130. Reis A.B., Martins-Filho O.A., Teixeira-Carvalho A., Carvalho M.G., Mayrink W., França-Silva J.C., Giunchetti R.C., Genaro O., Corrêa-Oliveira R. – Parasite density and impaired biochemical/hematological status are associated with severe clinical aspects of canine visceral leishmaniasis – Res. Vet. Sci. 2006 Aug;81(1):68-75. Epub 2005 Nov 8 [link];
  131. Reithinger R., Coleman P.G., Alexander B., Vieira E.P., Assis G., Davies C.R. – Are insecticide-impregnated dog collars a feasible alternative to dog culling as a strategy for controlling canine visceral leishmaniasis in Brazil? – Int. J. Parasitol. 2004 Jan;34(1):55-62 [link];
  132. Ribeiro, J.M. – Blood-feeding arthropods: live syringes or invertebrate pharmacologists? – Infect. Agents Dis. 1995 Sep;4(3):143-52 [link];
  133. Rioux J. A., Lanotte J., Destombes P., Vollhardt Y., Croset H. – Leishmaniosis expérimentale du Renard Vulpes vulpes (L.) – Récueil de Médécine Vétérinaire 1971;147:489-98;
  134. Rivò G., Poggi M., Mignone W., Mancianti F. – Immunomigrazione nella diagnosi sierologica della leishmaniosi canina: prova comparativa con l’immunofluorescenza indiretta – Veterinaria, Anno 14, n. 2, Agosto 2000:61-4;
  135. Rosypal AC, Gogal RM Jr, Zajac AM, Troy GC, Lindsay DS – Flow cytometric analysis of cellular immune responses in dogs experimentally infected with a North American isolate of Leishmania infantum – Vet Parasitol. 2005 Jul 15;131(1-2):45-51 [link];
  136. Rosypal AC, Lindsay DS – Non-sand fly transmission of a North American isolate of Leishmania infantum in experimentally infected BALB/c mice – J Parasitol. 2005 Oct;91(5):1113-5 [link];
  137. Rosypal AC, Troy GC, Zajac AM, Frank G, Lindsay DS – Transplacental transmission of a North American isolate of Leishmania infantum in an experimentally infected beagle – J Parasitol. 2005 Aug;91(4):970-2 [link];
  138. Roura X. – Scelte diagnostico-terapeutiche difficili in corso di leishmaniosi canina – Atti Incontro SIDEV 25 febbraio 2001;
  139. Roura X. – Uso della PCR nella diagnosi della leishmaniosi canina – Atti Incontro SIDEV 25 febbraio 2001;
  140. Rüfenacht S., Sager H., Müller N., Schaerer V., Heier A., Welle M.M., Roosje P.J. – Two cases of feline leishmaniosis in Switzerland – Vet. Rec. 2005 Apr 23;156(17):542-5 [link];
  141. Sanchez M.A., Diaz N.L., Zerpa O., Negron E., Convit J., Tapia F.J. – Organ-specific immunity in canine visceral leishmaniasis: analysis of symptomatic and asymptomatic dogs naturally infected with Leishmania chagasi – Am. J. Trop. Med. Hyg. 2004 Jun;70(6):618-24 [abstractHTMLPDF];
  142. Santiago ME, Vasconcelos RO, Fattori KR, Munari DP, Michelin Ade F, Lima VM – An investigation of Leishmania spp. in Didelphis spp. from urban and peri-urban areas in Bauru (São Paulo, Brazil) – Vet Parasitol. 2007 Dec 25;150(4):283-90. Epub 2007 Nov 8 [abstract];
  143. Schubach A, Cuzzi-Maya T, Gonçalves-Costa SC, Pirmez C, Oliveira-Neto MP – Leishmaniasis of glans penis – J Eur Acad Dermatol Venereol. 1998 May;10(3):226-8 [link];
  144. Shaw J.J. – New World Leishmaniasis: The Ecology of Leishmaniasis and the Diversity of Leishmanial Species in Central and South America – In World Class Parasites: Volume 4 – Leishmania – ed. Jay P. Farrell, Kluwer Academic Publishers, Boston, Dordrech, London, 11-31, 2002;
  145. Silva FL, Rodrigues AA, Rego IO, Santos RL, Oliveira RG, Silva TM, Xavier MN, Nascimento EF, Santos RL – Genital lesions and distribution of amastigotes in bitches naturally infected with Leishmania chagasi – Vet Parasitol. 2007 Oct 7 [Epub ahead of print] [abstract];
  146. Sindermann H, Engel J – Development of miltefosine as an oral treatment for leishmaniasis – Trans R Soc Trop Med Hyg, 2006 Dec;100 Suppl 1:S17-20 [abstract];
  147. Slappendel RJ, Ferrer L – Leishmaniasis – In: Greene GE (Ed.), Infectious Diseases of the Dog and the Cat – WB Saunders, Philadelphia:450-8;
  148. Solano-Gallego L, Llull J, Arboix M, Ferrer L, Alberola J – Evaluation of the efficacy of two leishmanins in asymptomatic dogs – Vet Parasitol. 2001 Dec 3;102(1-2):163-6 [link];
  149. Stanneck D – Moderni approcci alla prevenzione delle malattie trasmesse da vettori nel cane – Atti 53° Congr. Naz. Multi. SCIVAC:279-80 – Rimini, maggio 2006 [PDF];
  150. Strauss-Ayali D., Jaffe C.L., Burshtain O., Gonen L., Baneth G. – Polymerase chain reaction using noninvasively obtained samples, for the detection of Leishmania infantum DNA in dogs – J. Infect. Dis. 2004 May 1;189(9):1729-33 [abstractHTMLPDF];
  151. Strauss-Ayali D, Baneth G, Shor S, Okano F, Jaffe CL – Interleukin-12 augments a Th1-type immune response manifested as lymphocyte proliferation and interferon gamma production in Leishmania infantum-infected dogs – Int J Parasitol. 2005 Jan;35(1):63-73. Epub 2004 Dec 8 [link];
  152. Symmers WS – Leishmaniasis acquired by contagion: a case of marital infection in Britain – Lancet. 1960 Jan 16;1:127-32;
  153. Tselentis Y., Gikas A., Chaniotis B. – Kala-azar in Athens basin – Lancet. 1994;343:1635;
  154. Vanloubbeeck Y.F., Ramer A.E., Jie F., Jones D.E. – CD4+ Th1 cells induced by dendritic cell-based immunotherapy in mice chronically infected with Leishmania amazonensis do not promote healing – Infect Immun. 2004 Aug;72(8):4455-63 [abstractHTMLPDF];
  155. van Zandbergen G., Klinger M., Mueller A., Dannenberg S., Gebert A., Solbach W., Laskay T. – Cutting edge: neutrophil granulocyte serves as a vector for Leishmania entry into macrophages – J. Immunol. 2004 Dec 1;173(11):6521-5 [abstractHTMLPDF];
  156. Winberg ME, Rasmusson B, Sundqvist T – Leishmania donovani: Inhibition of phagosomal maturation is rescued by nitric oxide in macrophages – Exp Parasitol. 2007 Oct;117(2):165-70. Epub 2007 Apr 14 [link];
  157. Xavier SC, de Andrade HM, Monte SJH, Chiarelli IM, Lima WG, Michalick MSM, Tafuri WL, Tafuri WL – Comparison of paraffin-embedded skin biopsies from different anatomical regions as sampling methods for detection of Leishmania infection in dogs using histological, immunohistochemical and PCR methods – BMC Veterinary Research 2006, 2:17 (doi:10.1186/1746-6148-2-17) [abstractHTMLPDF];
  158. Zaffaroni E., Rubaudo L., Lanfranchi P., Mignone W. – Epidemiological patterns of canine leishmaniasis in Western Liguria (Italy) – Vet. Parasitol. 1999;81:11-9 [link];
  159. AA. VV. – Enciclopedia Oxford di veterinaria – ed. italiana Franco Muzzio, 1992;
  160. AA. VV. – La leishmaniosi canina – SCIVAC, 1989.
Ramos Franco A. M.: “First World Congress on Leishmaniasis – World Leish 1”. Mem. Inst. Osw. Cruz, 92(6):867-70, 1997

[Stampa] [Stampa]

Ultima modifica: 13 novembre 2014 @ 21:02 55''
(Modifica: aggiunta link)